(1)
THE ROLE OF DYSHORMONAL DISORDERS OF LEPTIN AND GHRELIN IN THE DEVELOPMENT OF DYSLIPIDEMIA AND METABOLIC SYNDROME. MAJMHS 2026, 2 (3), 7-16.